肠球菌的临床感染与耐药性分析

目的了解温州医学院附属第一医院临床分离主要肠球菌的分布及其对常用抗菌药物的耐药现状,以指导临床合理用药。方法对2008年至2011年临床分离的635株粪肠球菌和屎肠球菌的标本来源和药敏结果进行回顾性分析。结果各种临床标本中两种肠球菌的分布比例存在差异,总体以尿液标本所占比例最多,且屎肠球菌的总体分离率高于粪肠球菌。粪肠球菌对利奈唑胺、氨苄西林、万古霉素、呋喃妥因和替考拉宁的耐药率都在5．0％以下,对莫西沙星和青霉素G的耐药率也仅为7．0％和6．7％;屎肠球菌对莫西沙星、左旋氧氟沙星、环丙沙星、氨苄西林、青霉素G和红霉素的耐药率都在90．0％以上,对利奈唑胺、万古霉素、替考拉宁和奎奴敏感。粪肠球菌的多重耐药株占总数的26．4％,屎肠球菌的多重耐药株占总数的78．2％。结论粪肠球菌和屎肠球菌对15种抗菌药物的耐药情况不同,屎肠球菌具有更高的耐药率和更广的耐药谱。临床应根据药敏试验的结果合理选择抗菌药物,以防止耐药菌株的产生和播散。     

重庆市1264株粪肠球菌和屎肠球菌耐药性监测

【摘 要】 目的 了解2011年中国重庆市主要7所教学医院临床分离粪肠球菌和屎肠球菌对各类抗菌药物的耐药性。方法 重庆市主要7所教学医院(6所综合性医院,1所儿童医院)按统一方案、采用统一的材料、方法和判断标准(CLSI 2011年版)进行粪肠球菌和屎肠球菌的耐药性监测。数据用WHONET 5.5软件按照CLSI 2011年版折点进行分析。结果 共分离到非重复粪肠球菌589株、屎肠球菌675株,对利奈唑胺、万古霉素、替考拉宁仍极敏感,耐药率<2%,万古霉素耐药粪肠球菌和屎肠球菌检出率分别为0.3%、0.7%。粪肠球菌对青霉素、氨苄西林、呋喃妥因的耐药率较低,分别为14.8%、8.6%和5.1%,对高浓度庆大霉素的耐药率分别为46.9%;屎肠球菌耐药性明显高于粪肠球菌,对青霉素和氨苄西林耐药率接都在90％左右。儿童和成人耐药率存在一定差别。结论 本市医院肠球菌感染以屎肠球菌为主, 粪肠球菌次之,两者耐药性明显不同, 监测其耐药情况对指导临床用药具有重要意义。     

乳酸菌Enterococcuse faecalis TN-9低温蛋白酶的提纯及性质

对产自乳酸菌Enterococcuze fecalis TN-9的蛋白酶,进行了硫酸铵沉淀,DEAE—Sephadex A-25以及DEAE Cellulofine A-500离子交换层析的3步纯化和特性研究。纯化酶Native PAGE显示1条蛋白带。SDSPAGE和凝胶层析分子量分别为30ku及69ku。纯化酶最适作用温度为30℃,最适作用PH为7．5～8．0,在pH6．0～9．5和45℃以下条件下稳定,在0℃下显示了6．1％的相对活性,60℃以上热处理完全失去酶活。该酶被EDTA-2Na,Hg^2＋、Cu^2＋、Ni^2＋、Ag^2＋、Co^2＋及Pepstatin A不完全抑制。Zn^2＋对蛋白酶具有明显的激活作用。纯化酶作用于偶氮酪蛋白的Km和Vmax分别为0．098％和72mg／（h·mg）。该酶为N末端VGSEVTLKNS的明胶酶（Gelatinase）的一种,性质属于低温蛋白酶。     

肠球菌属细菌的临床分布与耐药性分析

目的了解2012-2017年临床分离肠球菌的分布特征及耐药性,为临床合理用药提供依据。方法采用全自动微生物分析仪进行菌株鉴定及药敏试验,对肠球菌的临床分布与耐药情况进行统计分析。结果共分离出1 432株肠球菌,其中粪肠球菌为603株(42.11%),屎肠球菌为596株(41.62%)。肠球菌属细菌标本来源以尿液、胆汁和全血为主,分别占39.66%、34.50%和11.59%,其中粪肠球菌主要来自普外科、泌尿外科和ICU,而屎肠球菌主要来自ICU、普外科和消化内科。肠球菌总体对红霉素的耐药率最高(67.81%),其次为四环素(47.49%)、环丙沙星(47.00%)和左旋氧氟沙星(46.44%),对利奈唑胺和万古霉素的耐药率较低,分别为4.89%和1.19%。粪肠球菌对奎奴普丁/达福普汀、四环素的耐药率分别为83.91%和64.01%,明显高于屎肠球菌(均P0.05)。屎肠球菌对红霉素、青霉素G、氨苄西林、喹诺酮类的耐药率均超过85.00%,且均高于粪肠球菌(均P0.05)。粪肠球菌和屎肠球菌对利奈唑胺的耐药率分别为6.80%和2.18%,对万古霉素的耐药率分别为0.66%和0.67%。结论肠球菌感染病原菌以粪肠球菌和屎肠球菌为主,肠球菌属细菌对万古霉素和利奈唑胺仍然保持较高的敏感性,不同种的肠球菌其耐药性差异显著。     

Surface charge influences enterococcal prevalence in mixed-species biofilms

AIM: To study the influence of 15 microbial isolates on the prevalence of charge-heterogeneous and charge-homogeneous Enterococcus faecalis strains, all isolated from biliary stents, in mixed-species biofilms. METHODS AND RESULTS: Six Enterococcus faecalis strains were paired with 15 other microbial isolates to form mixed-species biofilms in a microtitre plate assay. Charge-heterogeneous Enterococcus faecalis strains display two subpopulations with different surface charges, expressed as a biomodal zeta potential distribution. It was found that, in general, the prevalence of the charge-heterogeneous, biofilm forming Enterococcus faecalis was reduced in mixed-species biofilms. The prevalence of charge-homogeneous, nonbiofilm-forming Enterococcus faecalis strains was increased only in the presence of Citrobacter freundii BS5126, Stenotrophomonas malthophilia BS937, and Candida lusitaniae BS8256, all of which introduced sizeable charge heterogeneity in the mixed microbial population. CONCLUSIONS: Charge-homogeneous Enterococcus faecalis strains are stimulated to form biofilm only by the presence of another microbial species with a considerably less negative zeta potential, thereby creating a charge-heterogeneous microbial population. SIGNIFICANCE AND IMPACT OF THE STUDY: Enterococcus faecalis is one of the predominant species isolated from mixed-species biofilms in clogged biliary stents. The current study shows how charge-homogeneous Enterococcus faecalis strains form more biofilm in the presence of other microbial species.     

水溶性蜂胶对感染根管内粪肠球菌的体外抑菌试验

目的 研究水溶性蜂胶对感染根管内常见菌粪肠球菌的体外抑菌活性.方法 采用液体稀释法测定水溶性蜂胶对粪肠球菌的最低杀菌浓度(Minimal bactericidal concentrations,MBC).结果 蜂胶对粪肠球菌的MBC为0.156%.结论 蜂胶对感染根管内粪肠球菌具有良好的抑菌活性,将其用于感染根管消毒具...     

耐利奈唑胺粪肠球菌感染的危险因素分析

分析深圳市南山区人民医院粪肠球菌感染患者的临床资料,探讨引起感染的危险因素,为防治耐利奈唑胺粪肠球菌感染提供临床参考。选取2010年1月-2015年9月在深圳市南山区人民医院住院的165例粪肠球菌感染患者,根据药敏结果分为利奈唑胺敏感组(103例)和利奈唑胺中介/耐药组(62例)。165例粪肠球菌主要来源于中段尿培养,占53.94%,其次为伤口分泌物培养(21.82%)、血培养(6.06%);科室分布以泌尿外科和肝胆外科为主,分别占35.76%和9.70%。单因素分析显示,碳青霉烯类抗生素暴露、留置尿管与感染相关。Logistic回归分析进一步明确碳青霉烯类抗生素暴露、留置尿管为耐利奈唑胺粪肠球菌感染的危险因素,提示应严格掌握碳青霉烯类抗生素的适应证,加强医院内感染的控制管理。     

Isolation and characterization of a novel Enterococcus faecalis bacteriophage φEF24C as a therapeutic candidate

Vancomycin-resistant Enterococcus faecalis (VRE) has become a significant threat in nosocomial settings. Bacteriophage (phage) therapy is frequently proposed as a potential alternative therapy for infections caused by this bacterium. To search for candidate therapeutic phages against Enterococcus faecalis infections, 30 Enterococcus faecalis phages were isolated from the environment. One of these, virulent phage φEF24C, which has a broad host range, was selected for analysis. The plaque-forming ability of φEF24C was virtually unaffected by differences in the clinical host strains. Furthermore, the phage had a shorter latent period and a larger burst size than ordinary tailed phages, indicating that φEF24C has effective lytic activity against many Enterococcus faecalis strains, including VRE. Morphological and genomic analyses revealed that φEF24C is a large myovirus (classified as family Myoviridae morphotype A1) with a linear double-stranded DNA genome of c . 143 kbp. Analyses of the N-terminal amino acid sequences of the virion proteins, together with the morphology and the genome size, speculated that φEF24C is closely related to other myoviruses of Gram-positive bacteria that have been used experimentally or practically for therapy or prophylaxis. Considering these results, φEF24C may be a potential candidate therapeutic phage against Enterococcus faecalis infections.     

牦牛肠道粪肠球菌的分离和鉴定

试验为获得1株与牦牛肠道共生的粪肠球菌,通过对健康牦牛粪样中的肠球菌进行分离培养、革兰染色、生化试验、16S rRNA基因测序比对等生物学鉴定,初步证实该分离菌株为粪肠球菌。此试验为进一步分析牦牛肠道菌群结构,探索牦牛耐饥、耐渴、耐粗饲、对高山草原极强适应性与其肠道菌群的关系,进一步研究与牦牛共生的粪肠球菌的生物学特性、生理特性、对宿主危害性等提供一些实验依据。     

一株产纤溶酶菌株的分离、鉴定及其酶活特征的初步研究

[目的]分离筛选并鉴定产纤溶酶的菌株.[方法]采用血粉培养基富集,琼脂糖-纤维蛋白平板筛选,从自然界中分离筛选出一株产纤溶活性物质的菌株.通过形态学特征、生理生化特征研究,并结合16S rRNA基因序列分析及分子系统发育树的构建结果,确定菌株的种类.[结果]从自然界分离筛到一株产纤溶酶的菌株EF608,经鉴定该菌株为粪肠球菌(Enterococcus faecalis). SDS-PAGE和纤维蛋白自显影表明该纤溶酶的分子量为37 kD,最适反应温度和pH分别为35℃和7.5,EDTA能完全抑制其纤溶活性,而PMSF对其活性无抑制作用.菌株EF608发酵液不仅可以直接水解纤维蛋白,而且具有体外溶栓的作用,对血红细胞没有溶解作用.[结论]筛选到一株具有纤溶活性的粪肠球菌——EF608,为获取新型纤溶酶提供了一种的新的菌源.     

Comparison of vancomycin-inducible proteins from four strains of Enterococci

Vancomycin-inducible proteins of 39.5 and 39 kDa from respectively, low-level and high-level resistant Enterococci were compared. Electrophoretic, immunoblot and peptide analysis revealed three types of protein, one in a low-level resistant strain of E. faecium, one in 2 high-level-resistant strains of E. faecium, and one in a high-level resistant strain of E. faecalis. The inducible proteins of E. faecium and E. faecalis, of 39.5 and 39 kDa respectively, which may function in a similar fashion (Al-Obeid et al. (1990) Antimicrob. Agents Chemother. 34, 252-256), are not related immunologically.     

临床分离肠球菌的分布特点及耐药性变迁

目的分析临床分离肠球菌的分布特点及耐药性变迁,为临床合理应用抗生素提供依据。方法从中国医科大学附属盛京医院门诊和住院病人采集血液、尿液、手术切口分泌物、腹腔引流液等标本,应用法国生物梅里埃API细菌鉴定系统进行细菌的分离和种属鉴定,用K-B纸片琼脂扩散方法对不同肠球菌做药物敏感试验。结果肠球菌属的数量占全部分离到细菌种类的第6位。其中屎肠球菌的构成比,2002年为30.9%,2006年上升到71.6%,超过粪肠球菌的比例。肠球菌主要分布于ICU、普通外科、呼吸内科、肾内科、干诊、感染科和新生儿科病房。粪肠球菌对青霉素、氨苄西林和呋喃妥因的耐药率分别从2002年的53.6%、38.5%和30.4%下降到2006年的4.5%、0和4.5%,屎肠球菌对氯霉素的耐药率从2002年的37.1%下降到2006年的14.3%,两种菌对万古霉素和替考拉宁的敏感性均高,但临床出现耐万古霉素和耐替考拉宁的肠球菌。结论中国医科大学附属盛京医院临床肠球菌出现新的分布特点,屎肠球菌比例有增加趋势。调查肠球菌尤其是屎肠球菌感染的危险因素和采取相应的防治措施是当前研究的重要课题。     

Identification of lactic acid bacteria from spoilage associations of cooked and brined shrimps stored under modified atmosphere between 0 degrees C and 25 degrees C

AIMS: To evaluate spoilage and identify lactic acid bacteria (LAB) from spoilage associations of cooked and brined shrimps stored under modified atmosphere packaging (MAP) at 0, 5, 8, 15 and 25 degrees C. METHODS AND RESULTS: Bacterial isolates (102) from spoilage associations of cooked and brined MAP shrimps were characterized by phenotypic tests and identified as lactic acid bacteria (78 isolates), other Gram-positive bacteria (13 isolates) and Gram-negative bacteria (11 isolates). A selection of 48 LAB isolates were further characterized and identified by phenotypic tests and SDS-PAGE electrophoresis of whole cell proteins. Selected clusters of LAB isolates were analysed by plasmid profiling, pulsed field gel electrophoresis and 16S rRNA gene sequencing. Enterococcus faecalis was identified in spoilage associations at 15 degrees C and 25 degrees C, and its metabolic activity corresponded to chemical changes in spoiled products. Carnobacterium divergens, a non-motile Carnobacterium sp. nov. and Lactobacillus curvatus were the LAB species observed in spoilage associations of products stored at 0 degrees C, 5 degrees C and 8 degrees C. CONCLUSIONS: Enterococcus spp. and Carnobacterium spp. were the dominant parts of spoilage associations of cooked and brined MAP shrimps stored at high and low temperatures, respectively. SIGNIFICANCE AND IMPACT OF THE STUDY: The SDS-PAGE technique and simple biochemical keys allowed the majority of LAB isolates from spoilage associations of cooked and brined MAP shrimps to be identified at the species level.     

不同分离源粪肠球菌的毒力基因比较

【背景】粪肠球菌作为一种重要的乳酸菌在食品和医药领域应用广泛。由于很多粪肠球菌为条件致病菌,因此充分了解粪肠球菌基因组中毒力基因(Virulence genes)的携带情况对合理利用该菌种有重要的意义,但目前还没有研究专门报道不同分离源粪肠球菌基因组中毒力基因的携带情况。【目的】了解不同分离源粪肠球菌毒力基因的携带情况,评估分离自自然发酵乳制品中的粪肠球菌的安全性。【方法】利用比较基因组学方法确定107株分离自乳源、血液、尿液、粪便和水源中的粪肠球菌携带毒力基因情况,使用主成分分析比较不同分离源菌株毒力基因的差异,通过卡方检验筛查出环境特异性毒力基因。【结果】在107株粪肠球菌基因组共找到88种编码不同功能蛋白的毒力基因,其中与粘附相关的毒力基因最多。同时发现乳源分离株与其他环境分离株所携带的毒力基因没有显著差异。【结论】乳源分离株中携带的毒力基因与其他环境分离株无显著差异,表明分离自自然发酵乳制品中的粪肠球菌可能同样存在致病风险,因此在食品工业中使用粪肠球菌时一定要对菌株的安全性做全面的评估。     

Conjugal transfer of plasmid-borne bacteriocin production in Enterococcus faecalis 226 NWC

Enterococcus faecalis 226 NWC, isolated from natural whey cultures utilized as starter in water-buffalo Mozzarella cheese manufacture, produces a bacteriocin, designated Enterocin 226 NWC, which is inhibitory to Listeria monocytogenes. Plasmid analysis of E. faecalis 226 NWC showed a single 5.2-kb plasmid, pEF226. In conjugation experiments, pEF226 was transferred into a plasmid-free strain of E. faecalis JH2-2. The transfer required direct cell-to-cell contact and was not inhibited by DNase. The identity of conjugation was confirmed by digestion with SmaI restriction endonuclease and subsequent pulsed-field gel electrophoresis (PFGE) of the genomic DNA of E. faecalis 226, E. faecalis JH2-2 and of the isolates after the mating. The data indicate that the ability of E. faecalis 226 NWC to produce the bacteriocin is linked to the 5.2-kb conjugative plasmid pEF226.     

Influence of avilamycin administration and its subsequent withdrawal on emergence and disappearance of antimicrobial resistance in enterococci in the intestine of broiler chickens

AIMS: To investigate the influence of avilamycin (AVM) administration and its subsequent withdrawal on the emergence and disappearance of AVM-resistant enterococci in the intestine of broiler chickens. METHODS AND RESULTS: Five chicks each of C, L and H groups were given the basal diet, the basal diet supplemented with 5 g AVM/ton and the basal diet supplemented with 50 g AVM/ton, respectively. The AVM-resistant Enterococcus faecalis population did not emerge during 30 days of the AVM administration period, whereas the AVM-resistant Enterococcus faecium with a minimum inhibitory concentration of >512 microg ml(-1) in the faeces of chicks of the L and H groups emerged on 3 and 1 days after the AVM administration, respectively. Thereafter, the AVM-resistant Ent. faecium population density in both L and H groups maintained high levels during the AVM administration period. Twenty days after the AVM withdrawal, the AVM-resistant Ent. faecium population disappeared from the intestines of both four of five chicks of L group and three of five chicks of H group. The AVM-resistant Ent. faecium population density in one chick from each of the groups, L and H, did not change before and after the AVM removal. CONCLUSIONS: The AVM-resistant Ent. faecium emerged during the AVM administration, and disappeared from the intestine of most chicks after the AVM withdrawal. However, the AVM-resistant Ent. faecium persisted in some chicks 20 days after AVM withdrawal. SIGNIFICANCE AND IMPACT OF THE STUDY: Our results suggest that introducing an AVM withdrawal period could minimize the risk of AVM-resistant Ent. faecium becoming carcass contaminants, and that prudent antibiotic use alone is not sufficient to stem emergence of the AVM-resistant Ent. faecium.